Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Spinal Muscular Atrophy Therapies: ICER Grounds the Price to Value Conversation in FactsCatherine I Starner, Patrick P GleasonJournal of Managed Care & Specialty Pharmacy|October 25, 2022
Drug super spender tsunami: An integrated medical and pharmacy benefits assessmentCatherine I Starner, Kevin Bowen, Patrick P GleasonJournal of Managed Care Pharmacy : JMCP|June 4, 2010
Pharmacy students' views of managed care pharmacy and PBMS: should there be more exposure to managed care in the pharmacy curriculum?Amy L Pittenger, Catherine I Starner, Kaj Thompson, et al.Journal of Managed Care & Specialty Pharmacy|June 5, 2023
Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosisLandon Z Marshall, Rachel Espinosa, Catherine I Starner, et al.Journal of Managed Care & Specialty Pharmacy|November 25, 2016
Association of a Controlled Substance Scoring Algorithm with Health Care Costs and Hospitalizations: A Cohort StudyCatherine I Starner, Yang Qiu, Pinar Karaca-Mandic, et al.Journal of Managed Care Pharmacy : JMCP|April 4, 2012
Rosiglitazone prior authorization safety policy: a cohort studyCatherine I Starner, Beckie Fenrick, John Coleman, et al.The American Journal of Geriatric Pharmacotherapy|March 14, 2009
Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderlyCatherine I Starner, Sheila A Norman, Richard G Reynolds, et al.Journal of Managed Care Pharmacy : JMCP|August 13, 2008
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning eventsCatherine I Starner, Jeremy A Schafer, Alan H Heaton, et al.The American Journal of Managed Care|June 9, 2016
Sofosbuvir initial therapy abandonment and manufacturer coupons in a commercially insured populationTaruja D Karmarkar, Catherine I Starner, Yang Qiu, et al.Journal of Managed Care Pharmacy : JMCP|February 7, 2013
Dalfampridine prior authorization program: a cohort studyPatrick P Gleason, Jill Phillips, Beckie A Fenrick, et al.Pageof 4